Womens Imaging

Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.

ACR, SBI publish new breast cancer screening guidelines

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) have published new breast cancer screening guidelines, once again recommending that all women begin annual screening at age 40.

April 4, 2018

Updated ACR/SBI breast cancer screening guidelines recognize higher risk in black women

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) released updated breast cancer screening guidelines, April 4—the first to recognize black women face higher risks for the disease and should be screened accordingly.

April 4, 2018
screen_shot_2018-04-03_at_10.25.59_am.png

Revised mammography guidelines may explain breast screening decline in US

In 2009, the U.S. Preventative Services Task Force (USPSTF) revised its breast cancer screening guidelines. These changes may be one reason for a continuous decline in breast screening exams in the U.S. since 2010, according to results of a study published by the American Journal of Roentgenology.

April 3, 2018
screen_shot_2018-03-29_at_2.21.37_pm.png

Greater background parenchymal enhancement increases breast cancer risk

Researchers from Duke University Medical Center have found that women with greater than minimal background parenchymal enhancement (BPE) at an index MRI face increased risk of developing breast cancer, according to a study published online March 27 in Academic Radiology.

March 29, 2018
dollar-1362244_1920.jpg

Philadelphia woman quoted $351 for breast MRI—then charged $4,650

A Pennsylvania woman was shocked when quoted $351 for a breast MRI from the Crozer-Keystone Health System, before being billed $4,650 for the exam.  

March 19, 2018

FUJIFILM submits first PMA module for digital breast tomosynthesis

FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging solutions, has submitted to the U.S. Food and Drug Administration (FDA) the first module of its premarket approval (PMA) application for digital breast tomosynthesis* (DBT), as an optional upgrade for the Aspire Cristalle mammography system.

August 6, 2015